U.S. Physical Therapy (NYSE:USPH) Posts Earnings Results, Meets Expectations

U.S. Physical Therapy (NYSE:USPH) posted its quarterly earnings results on Wednesday. The company reported $0.67 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.67, Zacks reports. U.S. Physical Therapy had a net margin of 5.71% and a return on equity of 8.62%.

U.S. Physical Therapy Stock Down 1.3%

U.S. Physical Therapy stock traded down $1.11 during mid-day trading on Wednesday, reaching $81.77. The stock had a trading volume of 163,037 shares, compared to its average volume of 222,374. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $93.50. The company has a 50-day moving average price of $83.43 and a two-hundred day moving average price of $82.58. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of 34.36, a PEG ratio of 3.45 and a beta of 1.30. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.20 and a quick ratio of 1.20.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of USPH. Advisory Services Network LLC bought a new position in U.S. Physical Therapy in the third quarter worth approximately $39,000. iSAM Funds UK Ltd purchased a new stake in shares of U.S. Physical Therapy in the 3rd quarter worth $52,000. Aquatic Capital Management LLC raised its holdings in U.S. Physical Therapy by 445.4% in the 3rd quarter. Aquatic Capital Management LLC now owns 1,369 shares of the company’s stock worth $116,000 after purchasing an additional 1,118 shares during the period. Vestcor Inc purchased a new position in U.S. Physical Therapy during the third quarter valued at $117,000. Finally, State of Wyoming grew its holdings in U.S. Physical Therapy by 85.3% during the second quarter. State of Wyoming now owns 1,575 shares of the company’s stock valued at $123,000 after purchasing an additional 725 shares during the period.

Wall Street Analyst Weigh In

Several brokerages have commented on USPH. JPMorgan Chase & Co. cut their target price on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Monday, November 24th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Finally, Barrington Research reiterated an “outperform” rating and set a $103.00 price objective on shares of U.S. Physical Therapy in a research report on Friday, February 20th. Four equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and a consensus price target of $105.33.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.